In vitro moisturizing efficacy testing provides scientifically robust, ethically favorable, and cost-effective evidence to substantiate hydration claims for cosmetics and personal care products. By combining gravimetric hydration assays, reconstructed human epidermis (RhE) models, and cell-based biomarker analysis, accredited third-party laboratories can precisely quantify how effectively a formulation absorbs, retains, and delivers water. This article explains the technical principles, sample requirements, test items, methodologies, and regulatory applications of in vitro moisturizing evaluation for cosmetics.
Technical Overview
Moisturizing efficacy refers to the capacity of a cosmetic product or ingredient to increase the water content of the stratum corneum, strengthen the skin barrier, and reduce transepidermal water loss (TEWL). Skin hydration is governed by three functional classes of ingredients: humectants (such as glycerin, hyaluronic acid, and betaine) that attract and bind water; emollients that soften and smooth the skin surface; and occlusive agents that form a hydrophobic film to limit evaporation. An effective moisturizing formulation typically acts through a combination of these mechanisms.
In vitro moisturizing testing evaluates these mechanisms without the use of human volunteers or animals, relying instead on controlled physical measurements, reconstructed three-dimensional skin tissue, and cell-based bioassays. Because the in vitro environment is highly standardized, results are reproducible, rapid to obtain, and well suited to formulation screening and claim substantiation. Under China's Cosmetic Supervision and Administration Regulation (CSAR) and the associated Cosmetic Efficacy Claim Evaluation framework, laboratory data such as in vitro test results, together with literature or research data, can be used to substantiate moisturizing claims. Internationally, in vitro approaches are supported by validated methodology principles published by standards organizations such as the OECD, ISO, and ASTM, including OECD Test Guidelines on reconstructed human epidermis models and ASTM water vapor transmission methodology.
Testing Samples
Finished Cosmetic Products
Complete, market-ready or pilot-batch formulations submitted in their final packaging are the most common sample type. Typical product categories include:
- Face and body creams, lotions, and milks
- Serums, essences, and ampoules
- Toners, facial mists, and lotions
- Sheet masks, sleeping masks, and gel masks
- Hydrating gels, eye creams, hand creams, and lip care products
For each test, laboratories generally require 30 to 50 grams or milliliters per sample, ideally representing the final commercial formulation. Sample identity information such as batch number, production date, shelf life, and full ingredient list (INCI) should accompany the submission to ensure traceable and interpretable results.
Raw Materials and Functional Ingredients
Individual moisturizing actives are frequently evaluated independently to characterize their hydration performance and support ingredient-level marketing claims. Commonly tested materials include:
- Hyaluronic acid and its sodium salt across various molecular weight ranges
- Polyols such as glycerin, propylene glycol, and butylene glycol
- Betaine, panthenol, and taurine derivatives
- Amino acid-based NMF components and saccharide isomerate
- Polysaccharides, ectoin, and other natural-source humectants
- Occlusive agents such as plant butters, waxes, and silicone derivatives
For raw materials, testing is typically performed at the recommended use concentration and, where appropriate, across a dilution series to establish a dose–response relationship. Reference humectants such as glycerin are run in parallel as positive controls.
Testing Items
In vitro moisturizing evaluation can be structured around physical hydration parameters and biological biomarkers. The principal test items include:
- Moisture absorption capacity (hygroscopicity) under controlled high-humidity conditions
- Moisture retention capacity after transfer to a low-humidity environment
- Skin model hydration index measured by capacitance- or conductance-based probes
- Water vapor transmission rate (WVTR) and calculated occlusivity factor
- Reduction of transepidermal water loss across reconstructed epidermis models
- Cell viability and barrier integrity assessment (MTT or equivalent assays)
- Expression of hydration-related biomarkers, including aquaporin-3 (AQP3), filaggrin, involucrin, and hyaluronan synthase (HAS2)
- Hyaluronic acid secretion quantified by enzyme-linked immunosorbent assay (ELISA)
Test items are selected according to the product type, the claimed mechanism of action, and the intended regulatory or marketing use of the data.
Testing Methods
Gravimetric Moisture Absorption and Retention Assay
This classical method quantifies the fundamental water-binding performance of humectants and finished products. Test samples are placed in open vessels inside desiccators maintained at defined relative humidity levels using saturated salt solutions, for example approximately 43% relative humidity (saturated potassium carbonate) and approximately 81% relative humidity (saturated ammonium sulfate), with temperature controlled at room conditions. Samples are weighed at defined intervals, such as 1, 2, 4, 6, 8, and 24 hours, and the moisture absorption rate is calculated as the percentage of mass gain relative to the initial sample mass. The samples are then transferred to a dry, low-humidity environment to determine the moisture retention rate, which reflects the ability of the material to hold absorbed water under desiccating conditions. Glycerin is routinely included as a benchmark control, and the resulting absorption–retention curves allow direct ranking of candidate humectants.
Reconstructed Human Epidermis (RhE) Model Assay
Three-dimensional reconstructed human epidermis models, cultured from human keratinocytes to form a differentiated, multi-layered epidermis, provide a physiologically relevant platform that mirrors key features of the stratum corneum and living epidermal layers. The test product is applied topically to the model surface under standardized dosing conditions, followed by a defined incubation period. Endpoint measurements include tissue hydration determined with capacitance- or conductance-based instrumentation, water loss across the tissue measured by TEWL-type instrumentation, and tissue viability assessed by MTT reduction in line with the principles of OECD Test Guideline 431. Histological examination and immunostaining can further reveal effects on stratum corneum structure and differentiation markers such as filaggrin and involucrin. Because RhE models are accepted internationally as alternatives to animal testing, they are particularly valuable for cruelty-free brand positioning and for regulatory markets that restrict animal experimentation.
Cell-Based Biomarker Assays
Monolayer cultures of immortalized human keratinocyte lines or primary epidermal keratinocytes, and where relevant dermal fibroblasts, are used to evaluate the biological activity of moisturizing actives. Cells are exposed to non-cytotoxic concentrations of the test material, which are first established through viability assays such as MTT or CCK-8. Molecular endpoints include AQP3 expression, a key water channel governing epidermal water transport; HAS2 gene expression and extracellular hyaluronic acid secretion measured by ELISA; and the expression of barrier and differentiation proteins quantified by RT-qPCR, Western blotting, or immunofluorescence. These assays demonstrate whether an ingredient actively stimulates the skin's own hydration machinery rather than merely acting as a passive water binder.
Occlusivity and Water Vapor Transmission Testing
For formulations whose moisturizing effect relies on occlusion, film-forming performance is measured using membrane-based diffusion systems consistent with ASTM water vapor transmission methodology. A controlled water- or agar-containing vessel is sealed with a permeable membrane, the test product is applied as a uniform film, and the rate of water evaporation is gravimetrically monitored over time against blank and reference controls. The resulting occlusivity factor quantifies the degree to which the product suppresses water evaporation, supporting claims related to long-lasting hydration and barrier protection.
Data Analysis and Reporting
All studies incorporate appropriate negative, vehicle, and positive controls, with replicate measurements subjected to statistical analysis to confirm significance. Final reports typically include the experimental design, raw and calculated data, comparison charts against controls, photographic or histological evidence where applicable, and a science-based conclusion on the moisturizing efficacy of the test article.
Applications
In vitro moisturizing test data serve multiple purposes across the product lifecycle:
- Formulation development and optimization, enabling rapid comparison of humectant systems before committing to human studies
- Raw material screening and supplier comparison for hydrating active ingredients
- Efficacy claim substantiation for regulatory filings and compliance with China's efficacy claim evaluation requirements
- Support for advertising and label claims such as long-lasting hydration, barrier strengthening, and moisture retention
- Batch-to-batch consistency verification as part of quality control programs
- Evidence packages for cruelty-free and animal-testing-free market positioning
By generating objective, quantitative evidence early in development, brands reduce the risk of failed clinical studies, accelerate time to market, and build credible scientific support for consumer-facing claims.
FAQ
Is in vitro data accepted for moisturizing claims in China?
Yes. Under the efficacy claim evaluation framework that took effect in 2021, moisturizing claims may be substantiated through laboratory test data, including in vitro results, combined where appropriate with literature or research data. Human clinical testing is not mandatory for basic moisturizing claims, although many brands conduct both to strengthen their evidence package.
How does in vitro testing differ from in vivo moisturizing testing?
In vivo testing measures skin hydration and transepidermal water loss on human volunteers using capacitance-based hydration probes and TEWL instrumentation under controlled environmental conditions. In vitro testing replaces human subjects with physical measurement systems, reconstructed skin models, or cultured cells, offering faster turnaround, lower cost, no panel recruitment, and suitability for high-throughput screening.
How much sample is required for testing?
For finished products, 30 to 50 grams or milliliters per sample is generally sufficient for gravimetric and model-based testing. Raw material evaluations may require smaller quantities, typically 10 to 20 grams, depending on the number of test concentrations. Samples should be submitted in stable, sealed packaging with completed submission documentation.
What is the typical turnaround time?
Gravimetric absorption and retention assays are usually completed within one to two weeks. Reconstructed tissue and cell-based studies, including biological replicates, molecular analysis, and reporting, typically require three to six weeks depending on the complexity of the test plan.
Which method is most suitable for my product?
Humectant raw materials are best characterized by gravimetric absorption–retention assays combined with hyaluronic acid secretion or AQP3 expression analysis. Finished leave-on products are most effectively evaluated on reconstructed human epidermis models using hydration and TEWL endpoints, while barrier-repair or long-lasting hydration claims benefit from the addition of occlusivity and differentiation biomarker testing. An accredited third-party laboratory can help design a test plan aligned with the specific claim and target market.
